- Lynx and Solexa in reverse merger
- Solexa Ltd. raises £7.9mm in Series B round
- Lynx and Solexa buy Manteia's DNA colony assets
- Solexa raises $17mm in private financing round
- Lynx Therapeutics raised $13M in 1st round financing
- Lynx sells $4mm in stock and warrants
- Struggling Lynx raises another $4mm
- Helicos BioSciences closes $27mm venture round
- US Genomics closes $25mm third round, then additional $7mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.